Ptc Therapeutics (PTCT) Return on Capital Employed Growth (3y) (2016 - 2026)
Ptc Therapeutics (PTCT) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 4,853.00 |
| 10 | Ptc Therapeutics | 6.32 Bn | 4.43 Bn | 244.52 Mn | 3,639.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,639.00 |
| Dec 31, 2025 | 8,432.00 |
| Sep 30, 2025 | 6,989.00 |
| Jun 30, 2025 | 6,451.00 |
| Mar 31, 2025 | 7,106.00 |
| Dec 31, 2024 | 22.00 |
| Sep 30, 2024 | 1,404.00 |
| Jun 30, 2024 | 347.00 |
| Mar 31, 2024 | -608.00 |
| Dec 31, 2023 | -2,257.00 |
| Sep 30, 2023 | -5,410.00 |
| Jun 30, 2023 | -2,816.00 |
| Mar 31, 2023 | -1,998.00 |
| Dec 31, 2022 | -1,897.00 |
| Sep 30, 2022 | -948.00 |
| Jun 30, 2022 | -1,082.00 |
| Mar 31, 2022 | -1,018.00 |
| Dec 31, 2021 | -1,284.00 |
| Sep 30, 2021 | -1,469.00 |
| Jun 30, 2021 | -610.00 |